At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Using Imaging to Assess Effects of THC on Brain Activity
In Brief
A clinical study evaluating Dronabinol, Ethanol, and 2 other interventions for Intoxication Alcohol and 2 related conditions. Completed, enrolled 316 participants across 1 site.
Detailed Summary
This study will assess effects of tetrahydrocannabinol (THC) and THC + alcohol in marijuana users on prefrontal brain activity, using functional near-infrared spectroscopy (fNIRS) during resting state and during memory task performance. Participants will complete fNIRS testing 120 minutes following THC or identical placebo (Phase 2A), or THC/ethanol, THC/placebo ethanol, placebo THC/ethanol, and placebo THC/placebo ethanol (Phase 2B), and oxygenated hemoglobin (HbO) concentration will be measured.
Study Details
Timeline
Interventions
Dronabinol at physician determined doses of 10-80mg designed to produce intoxication.
Oral Ethanol, dosed to obtain a breath alcohol concentration (BrAC) of approximately 0.05 BrAC (equal to 1-2 standard drinks).
Identical in appearance to active dronabinol (overencapsulation of both active and placebo dronabinol)
Placebo ethanol will consist of diet soda used in the active ethanol condition with 0.25ml ethanol floated on top to provide the odor of ethanol and blind the study drug.